Looking Back at 2022 & Moving Forward into 2023

Medicines 360 logo

Dear Friends of Medicines360 – Happy New Year!  2023 is already off to a roaring start and Medicines360 is excited to share the inaugural edition of “All Access,” our newly launched bulletin. With drug prices in the U.S. continuing to rise, breakthrough products and essential medications have become even more unaffordable, particularly for people without health insurance. As […]

Victories and Reflections on Medicines360 Policy Work in 2022

Medicines 360 logo

Nearly three years into the pandemic, it is impossible to ignore that the health care policy environment has been forever changed — and that change continues. The pandemic laid bare long-standing inequities in access for people of color, people with low incomes, LGBTQ+ people, women, and people who live at the intersections of these identities. […]

FDA Approves Medicines360’s LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Eight Years

Medicines 360 logo

FDA Approval of Extended Duration of Use Supports Medicines360’s Mission to Expand Women’s Access Nov. 14, 2022 SAN FRANCISCO – Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, announced today that the U.S. Food and Drug Administration (FDA) has approved Medicines360’s Supplemental New Drug Application (sNDA) to extend […]

Medicines360 Calls on U.S. Congress to Pass Affordability is Access Act Without Delay 

Medicines 360 logo

Legislation will ensure people across the country can access and afford over-the-counter birth control options and plan their own reproductive lives, on their own terms   San Francisco, CA – Medicines360 applauds congressional health care leaders Sens. Patty Murray, Mazie Hirono, and Catherine Cortez Masto and Reps. Ayanna Pressley, Ami Bera, and Alexandria Ocasio-Cortez for authoring […]

Defying Definitions and Breaking Down Barriers: Lessons from Medicines360’s Nonprofit Journey

Medicines 360 logo

Medicines360 has the unique distinction of being the longest-standing nonprofit pharmaceutical organization that has product available in the U.S. market. Its inception was an industry innovation, and its survival has required it to push boundaries and defy traditional definitions — all in service of improving health equity. For the Medicines360’s team, the value of this […]

In the Wake of Supreme Court Decision, Medicines360 Stands With Women

Medicines 360 logo

Nonprofit women’s health pharmaceutical organization affirms commitment to expand access to birth control in U.S San Francisco, CA – Today, following the Supreme Court’s release of the majority decision in  Dobbs v. Jackson Women’s Health Organization, Medicines360 CEO Tina Raine-Bennett, MD, MPH, released the following statement: “At Medicines360, our work is driven by our deep […]

Medicines360 Applauds HELP Committee for Including Critical Amendments on Nonprofit Pharma in Legislation Headed to Senate Floor  

Medicines 360 logo

Committee member Senator Rosen has been a leading voice supporting the nonprofit pharmaceutical model San Francisco, CA –  Earlier this week, the United States Senate Health, Education, Labor, and Pensions (HELP) Committee advanced the Food and Drug Administration Safety and Landmark Advancements (FDASLA Act/ S. 4348) Act to the full Senate floor with broad bipartisan […]

Medicines360 Applauds Sens. Rosen and Romney for Introducing Critical Legislation to Explore Benefits of Nonprofit Pharmaceutical Model 

Medicines 360 logo

Senator Rosen has been a leading voice supporting the nonprofit pharmaceutical model  San Francisco, CA –  Last week, U.S. Senators Jacky Rosen (D-NV) and Mitt Romney (R-UT), announced the introduction of the Advancing Affordable Medicines for Families Act (S. 4341), bipartisan legislation which would direct the Government Accountability Office (GAO) to conduct a report on […]